title: Pain relief induces dopamine release in the rat nucleus accumbens during the early but not late phase of neuropathic pain.
abstract: Comorbidity of chronic pain and depression has long been recognized in the clinic, and preclinical studies have reported depression-like behaviors in animal models of chronic pain. These findings suggest a common neuronal basis for chronic pain and depression. The neuronal pathway from the ventral tegmental area to the nucleus accumbens (NAc) is critical in the mesolimbic dopamine (DA) reward circuit, and dysfunction of this pathway has been implicated in depression. Although time-dependent development of depression-related behaviors has been reported in chronic pain animals, time-dependent functional changes in this pathway remain to be examined. To address this issue, we examined the effects of two types of rewards, pain relief by intrathecal injection of pregabalin (100μg in 10μL phosphate buffered saline) and 30% sucrose solution intake, on intra-NAc DA release in rats subjected to spinal nerve ligation (SNL). Specifically, the effects were investigated during the early (17-20days after ligation) and late (31-34days after ligation) phases of neuropathic pain. Pain relief increased the intra-NAc DA levels in the SNL rats during the early but not late phase of neuropathic pain. Intake of the sucrose solution increased the intra-NAc DA levels both in the SNL and sham animals during the early phase of neuropathic pain, while it induced DA release in the sham but not SNL animals during the late phase. These results suggest that dysfunction of the mesolimbic DA reward circuit develops in a time-dependent manner. Mesolimbic DA reward circuit dysfunction might be a common neuronal mechanism underlying chronic pain and depression, and a potential target for novel analgesic and antidepressant medications.
authors.affiliation: Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Kato
authors.affiliation: Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
authors.forename: Soichiro
authors.initials: S
authors.lastname: Ide
authors.affiliation: Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan. Electronic address: mminami@pharm.hokudai.ac.jp.
authors.forename: Masabumi
authors.initials: M
authors.lastname: Minami
mesh_terms: D000700:Analgesics / Q000008:administration & dosage; D000818:Animals; D004298:Dopamine / Q000378:metabolism*; D008026:Ligation; D009437:Neuralgia / Q000378:metabolism* / Q000517:prevention & control; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism*; D017288:Pain Threshold / Q000187:drug effects; D000069583:Pregabalin / Q000008:administration & dosage; D051381:Rats; D017207:Rats, Sprague-Dawley; D012201:Reward; D013127:Spinal Nerves / Q000293:injuries; D013395:Sucrose / Q000008:administration & dosage
chemical_list: D000700:Analgesics; D000069583:Pregabalin; D013395:Sucrose; D004298:Dopamine
keywords: Depression; Dopamine; Mesolimbic reward circuit; Neuropathic pain; Nucleus accumbens